 | • レポートコード：GIR-105X12813 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、注射用オマリズマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。注射用オマリズマブの種類別市場規模（注射用皮下粉末、皮下液（150mg/mL）、皮下液（75mg/0.5mL））、用途別市場規模（病院、クリニック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・注射用オマリズマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche、Novartis ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射用皮下粉末、皮下液（150mg/mL）、皮下液（75mg/0.5mL） ・用途別分析2016年-2026年：病院、クリニック ・注射用オマリズマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・注射用オマリズマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・注射用オマリズマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・注射用オマリズマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・注射用オマリズマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Omalizumab for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Omalizumab for Injection size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Omalizumab for Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Omalizumab for Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Omalizumab for Injection market are listed below:
Roche
Novartis
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Omalizumab for Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Omalizumab for Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Subcutaneous Powder For Injection
1.2.3 Subcutaneous Solution (150 mg/mL)
1.2.4 Subcutaneous Solution(75 mg/0.5 mL)
1.3 Market Analysis by Application
1.3.1 Overview: Global Omalizumab for Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Omalizumab for Injection Market Size & Forecast
1.4.1 Global Omalizumab for Injection Sales in Value (2016-2026))
1.4.2 Global Omalizumab for Injection Sales in Volume (2016-2026)
1.4.3 Global Omalizumab for Injection Price by Type (2016-2026) & (US$/Unit)
1.5 Global Omalizumab for Injection Production Capacity Analysis
1.5.1 Global Omalizumab for Injection Total Production Capacity (2016-2026)
1.5.2 Global Omalizumab for Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Omalizumab for Injection Market Drivers
1.6.2 Omalizumab for Injection Market Restraints
1.6.3 Omalizumab for Injection Trends Analysis
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Omalizumab for Injection Product and Services
2.1.4 Roche Omalizumab for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Omalizumab for Injection Product and Services
2.2.4 Novartis Omalizumab for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Omalizumab for Injection Sales by Manufacturer
3.1 Global Omalizumab for Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Omalizumab for Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Omalizumab for Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Omalizumab for Injection Manufacturer Market Share
3.4.2 Top 6 Omalizumab for Injection Manufacturer Market Share
3.5 Global Omalizumab for Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Omalizumab for Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Omalizumab for Injection Market Size by Region
4.1.1 Global Omalizumab for Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Omalizumab for Injection Revenue by Region (2016-2026)
4.2 North America Omalizumab for Injection Revenue (2016-2026)
4.3 Europe Omalizumab for Injection Revenue (2016-2026)
4.4 Asia-Pacific Omalizumab for Injection Revenue (2016-2026)
4.5 South America Omalizumab for Injection Revenue (2016-2026)
4.6 Middle East and Africa Omalizumab for Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Omalizumab for Injection Sales in Volume by Type (2016-2026)
5.2 Global Omalizumab for Injection Revenue by Type (2016-2026)
5.3 Global Omalizumab for Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Omalizumab for Injection Sales in Volume by Application (2016-2026)
6.2 Global Omalizumab for Injection Revenue by Application (2016-2026)
6.3 Global Omalizumab for Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Omalizumab for Injection Sales by Type (2016-2026)
7.2 North America Omalizumab for Injection Sales by Application (2016-2026)
7.3 North America Omalizumab for Injection Market Size by Country
7.3.1 North America Omalizumab for Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Omalizumab for Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Omalizumab for Injection Sales by Type (2016-2026)
8.2 Europe Omalizumab for Injection Sales by Application (2016-2026)
8.3 Europe Omalizumab for Injection Market Size by Country
8.3.1 Europe Omalizumab for Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Omalizumab for Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Omalizumab for Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Omalizumab for Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Omalizumab for Injection Market Size by Region
9.3.1 Asia-Pacific Omalizumab for Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Omalizumab for Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Omalizumab for Injection Sales by Type (2016-2026)
10.2 South America Omalizumab for Injection Sales by Application (2016-2026)
10.3 South America Omalizumab for Injection Market Size by Country
10.3.1 South America Omalizumab for Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Omalizumab for Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Omalizumab for Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Omalizumab for Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Omalizumab for Injection Market Size by Country
11.3.1 Middle East & Africa Omalizumab for Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Omalizumab for Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Omalizumab for Injection Typical Distributors
12.3 Omalizumab for Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Omalizumab for Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Omalizumab for Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Omalizumab for Injection Product and Services
Table 6. Roche Omalizumab for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Omalizumab for Injection Product and Services
Table 10. Novartis Omalizumab for Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Omalizumab for Injection Sales by Manufacturer (2019-2021e) & (K Units)
Table 12. Global Omalizumab for Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Omalizumab for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Omalizumab for Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Omalizumab for Injection Production Site of Key Manufacturer
Table 16. Global Omalizumab for Injection Sales by Region (2016-2021e) & (K Units)
Table 17. Global Omalizumab for Injection Sales by Region (2021-2026) & (K Units)
Table 18. Global Omalizumab for Injection Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Omalizumab for Injection Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 21. Global Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 22. Global Omalizumab for Injection Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Omalizumab for Injection Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Omalizumab for Injection Price by Type (2016-2021e) & (US$/Unit)
Table 25. Global Omalizumab for Injection Price by Type (2021-2026) & (US$/Unit)
Table 26. Global Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 27. Global Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 28. Global Omalizumab for Injection Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Omalizumab for Injection Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Omalizumab for Injection Price by Application (2016-2021e) & (US$/Unit)
Table 31. Global Omalizumab for Injection Price by Application (2021-2026) & (US$/Unit)
Table 32. North America Omalizumab for Injection Sales by Country (2016-2021e) & (K Units)
Table 33. North America Omalizumab for Injection Sales by Country (2021-2026) & (K Units)
Table 34. North America Omalizumab for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Omalizumab for Injection Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 37. North America Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 38. North America Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 39. North America Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 40. Europe Omalizumab for Injection Sales by Country (2016-2021e) & (K Units)
Table 41. Europe Omalizumab for Injection Sales by Country (2021-2026) & (K Units)
Table 42. Europe Omalizumab for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Omalizumab for Injection Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 45. Europe Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 46. Europe Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 47. Europe Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 48. Asia-Pacific Omalizumab for Injection Sales by Region (2016-2021e) & (K Units)
Table 49. Asia-Pacific Omalizumab for Injection Sales by Region (2021-2026) & (K Units)
Table 50. Asia-Pacific Omalizumab for Injection Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Omalizumab for Injection Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 53. Asia-Pacific Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 54. Asia-Pacific Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 55. Asia-Pacific Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 56. South America Omalizumab for Injection Sales by Country (2016-2021e) & (K Units)
Table 57. South America Omalizumab for Injection Sales by Country (2021-2026) & (K Units)
Table 58. South America Omalizumab for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Omalizumab for Injection Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 61. South America Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 62. South America Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 63. South America Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Omalizumab for Injection Sales by Country (2016-2021e) & (K Units)
Table 65. Middle East & Africa Omalizumab for Injection Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Omalizumab for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Omalizumab for Injection Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Omalizumab for Injection Sales by Type (2016-2021e) & (K Units)
Table 69. Middle East & Africa Omalizumab for Injection Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Omalizumab for Injection Sales by Application (2016-2021e) & (K Units)
Table 71. Middle East & Africa Omalizumab for Injection Sales by Application (2021-2026) & (K Units)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Omalizumab for Injection Typical Distributors
Table 75. Omalizumab for Injection Typical Customers
List of Figures
Figure 1. Omalizumab for Injection Picture
Figure 2. Global Omalizumab for Injection Sales Market Share by Type in 2020
Figure 3. Subcutaneous Powder For Injection
Figure 4. Subcutaneous Solution (150 mg/mL)
Figure 5. Subcutaneous Solution(75 mg/0.5 mL)
Figure 6. Global Omalizumab for Injection Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Global Omalizumab for Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Omalizumab for Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Omalizumab for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Omalizumab for Injection Sales (2016-2026) & (K Units)
Figure 31. Global Omalizumab for Injection Production Capacity (2016-2026) & (K Units)
Figure 32. Global Omalizumab for Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Omalizumab for Injection Market Drivers
Figure 34. Omalizumab for Injection Market Restraints
Figure 35. Omalizumab for Injection Market Trends
Figure 36. Global Omalizumab for Injection Sales Market Share by Manufacturer in 2020
Figure 37. Global Omalizumab for Injection Revenue Market Share by Manufacturer in 2020
Figure 38. Omalizumab for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Omalizumab for Injection Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Omalizumab for Injection Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Omalizumab for Injection Sales Market Share by Region (2016-2026)
Figure 42. Global Omalizumab for Injection Revenue Market Share by Region (2016-2026)
Figure 43. North America Omalizumab for Injection Revenue (2016-2026) & (USD Million)
Figure 44. Europe Omalizumab for Injection Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Omalizumab for Injection Revenue (2016-2026) & (USD Million)
Figure 46. South America Omalizumab for Injection Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Omalizumab for Injection Revenue (2016-2026) & (USD Million)
Figure 48. Global Omalizumab for Injection Sales Market Share by Type (2016-2026)
Figure 49. Global Omalizumab for Injection Revenue Market Share by Type (2016-2026)
Figure 50. Global Omalizumab for Injection Price by Type (2016-2026) & (US$/Unit)
Figure 51. Global Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 52. Global Omalizumab for Injection Revenue Market Share by Application (2016-2026)
Figure 53. Global Omalizumab for Injection Price by Application (2016-2026) & (US$/Unit)
Figure 54. North America Omalizumab for Injection Sales Market Share by Country (2016-2026)
Figure 55. North America Omalizumab for Injection Revenue Market Share by Country (2016-2026)
Figure 56. North America Omalizumab for Injection Sales Market Share by Type (2016-2026)
Figure 57. North America Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 58. Europe Omalizumab for Injection Sales Market Share by Country (2016-2026)
Figure 59. Europe Omalizumab for Injection Revenue Market Share by Country (2016-2026)
Figure 60. Europe Omalizumab for Injection Sales Market Share by Type (2016-2026)
Figure 61. Europe Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Omalizumab for Injection Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Omalizumab for Injection Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Omalizumab for Injection Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 66. South America Omalizumab for Injection Sales Market Share by Country (2016-2026)
Figure 67. South America Omalizumab for Injection Revenue Market Share by Country (2016-2026)
Figure 68. South America Omalizumab for Injection Sales Market Share by Type (2016-2026)
Figure 69. South America Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Omalizumab for Injection Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Omalizumab for Injection Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Omalizumab for Injection Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Omalizumab for Injection Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の皮下注射免疫グロブリン市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界の注射用滅菌溶液市場 2021：企業別、地域別、種類・用途別 The Sterile Solution for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の皮下植込み型除細動器市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Implantable Defibrillators market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の注射用ウロキナーゼ市場 2021：企業別、地域別、種類・用途別 The Urokinase for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 免疫グロブリン製剤の世界市場2018-2025 This study focuses on the production side and consumption side of Immune Globulin Subcutaneous, presents the global Immune Globulin Subcutaneous market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.In terms of production side, th…